What is the current annual cash from financing of GSK?

As of today, GSK annual cash from financing is -$3.96B

What is 1-year change in GSK annual cash from financing?

GSK annual cash from financing is up +24.44% year-over-year

What is 3-year change in GSK annual cash from financing?

GSK annual cash from financing is down -293.39% over the past 3 years

How far is GSK annual cash from financing from its all-time high?

GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on December 31, 2018

How does GSK annual cash from financing rank versus sector peers?

GSK annual cash from financing is higher than 1.68% of companies in Healthcare sector

When is GSK next annual earnings release?

The next annual earnings release for GSK is on February 3, 2027

What is the current quarterly cash from financing of GSK?

As of today, GSK quarterly cash from financing is $6.40B

What is GSK quarterly cash from financing most recent change?

GSK quarterly cash from financing was up +351.57% on September 30, 2026

What is 1-year change in GSK quarterly cash from financing?

GSK quarterly cash from financing is up +474.37% year-over-year

How far is GSK quarterly cash from financing from its all-time high?

GSK quarterly cash from financing is currently -44.99% below its historical high of $11.63B set on June 30, 2018

How does GSK quarterly cash from financing rank versus sector peers?

GSK quarterly cash from financing is higher than 99.90% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

What is the current TTM cash from financing of GSK?

As of today, GSK TTM cash from financing is $5.17B

What is GSK TTM cash from financing most recent change?

GSK TTM cash from financing was up +276.38% on September 30, 2026

What is 1-year change in GSK TTM cash from financing?

GSK TTM cash from financing is up +226.46% year-over-year

How far is GSK TTM cash from financing from its all-time high?

GSK TTM cash from financing is currently -48.87% below its historical high of $10.11B set on March 31, 2019

How does GSK TTM cash from financing rank versus sector peers?

GSK TTM cash from financing is higher than 99.81% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

GSK Plc (GSK) CFF History & Chart Since 1991

Annual CFF

-$3.96B$1.28B+24.44%

December 31, 2025

Summary

Current Value: As of today, GSK annual cash from financing is -$3.96B, up +24.44% on December 31, 2025
Historical Performance: GSK annual cash from financing is down -293.39% over the past 3 years, up +66.68% over the past 5 years
All-Time High Comparison: GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on December 31, 2018
3-Year Low Comparison: GSK annual cash from financing is +34.72% above its 3-year low of -$6.07B reached on December 31, 2023
Sector Comparison: GSK annual cash from financing is higher than 1.68% of companies in Healthcare sector

Cash From Financing Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash From Financing	Dec 31, 25	-$3.96B	+24.4%	-293.4%	+66.7%	+46.5%
Quarterly Cash From Financing	Sep 30, 26	$6.40B	+474.4%	+395.2%	+441.5%	+318.8%
TTM Cash From Financing	Sep 30, 26	$5.17B	+226.5%	+257.3%	+160.3%	+159.8%
Price	Nov 6, 26	$50.33	+6.9%	+44.7%	+13.5%	+11.1%
Annual Cash From Operations	Dec 31, 25	$9.62B	+23.7%	+17.9%	-1.9%	+1.4%
Annual Cash From Investing	Dec 31, 25	-$5.90B	-232.2%	+45.8%	-319.6%	-91.7%
Annual Dividends Paid	Dec 31, 25	$3.38B	+8.2%	-20.9%	-33.7%	-31.7%
Annual Total Debt	Dec 31, 25	$23.83B	+12.0%	-5.6%	-35.8%	+0.8%
Shares Outstanding	Nov 4, 26	2.00B	-0.4%	-1.2%	+0.1%	–

Cash From Financing Highs

GSK Annual Cash From Financing Highs Comparison
Period	High	Date	Current
3Y	$2.05B	N/A	-293.4%
5Y	$2.05B	Dec 31, 22	-293.4%
All	$4.90B	Dec 31, 18	-180.8%

Cash From Financing Lows

GSK Annual Cash From Financing Lows Comparison
Period	Low	Date	Current
3Y	-$6.07B	Dec 31, 23	+34.7%
5Y	-$11.89B	N/A	+66.7%
All	-$11.89B	Dec 31, 20	+66.7%

Cash From Financing History

Year	Value	Change
2025	-$3.96B	+24.4%
2024	-$5.24B	+13.6%
2023	-$6.07B	-396.3%
2022	$2.05B	+121.8%
2021	-$9.39B	+21.1%
2020	-$11.89B	-893.5%
2019	-$1.20B	-124.4%
2018	$4.90B	+168.1%
2017	-$7.20B	+6.3%
2016	-$7.69B	+20.2%
2015	-$9.64B	-25.1%
2014	-$7.70B	+0.4%
2013	-$7.73B	-90.7%
2012	-$4.05B	+53.7%
2011	-$8.76B	-18.3%
2010	-$7.40B	-136.6%
2009	-$3.13B	+48.1%
2008	-$6.02B	-107.9%

Year	Value	Change
2007	-$2.90B	+64.0%
2006	-$8.05B	-83.9%
2005	-$4.38B	+22.9%
2004	-$5.68B	-27.1%
2003	-$4.47B	+26.0%
2002	-$6.04B	-8.7%
2001	-$5.56B	-29.3%
2000	-$4.30B	-22.4%
1999	-$3.51B	-146.4%
1998	-$1.43B	+28.0%
1997	-$1.98B	+25.5%
1996	-$2.66B	-179.0%
1995	$3.36B	+5,659.7%
1994	$58.39M	+108.1%
1993	-$718.86M	+56.2%
1992	-$1.64B	-265.1%
1991	-$449.64M	-

FAQ

What is the current annual cash from financing of GSK?: As of today, GSK annual cash from financing is -$3.96B
What is 1-year change in GSK annual cash from financing?: GSK annual cash from financing is up +24.44% year-over-year
What is 3-year change in GSK annual cash from financing?: GSK annual cash from financing is down -293.39% over the past 3 years
How far is GSK annual cash from financing from its all-time high?: GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on December 31, 2018
How does GSK annual cash from financing rank versus sector peers?: GSK annual cash from financing is higher than 1.68% of companies in Healthcare sector
When is GSK next annual earnings release?: The next annual earnings release for GSK is on February 3, 2027

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Quarterly CFF

$6.40B$8.94B+351.57%

September 30, 2026

Summary

Current Value: As of today, GSK quarterly cash from financing is $6.40B, up +351.57% on September 30, 2026
Historical Performance: GSK quarterly cash from financing is up +474.37% year-over-year, up +395.16% over the past 3 years
All-Time High Comparison: GSK quarterly cash from financing is currently -44.99% below its historical high of $11.63B set on June 30, 2018
3-Year Low Comparison: GSK quarterly cash from financing is +257.39% above its 3-year low of -$4.06B reached on December 31, 2023
Sector Comparison: GSK quarterly cash from financing is higher than 99.90% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash From Financing	Sep 30, 26	$6.40B	+351.6%	+474.4%	+395.2%	+441.5%
Annual Cash From Financing	Dec 31, 25	-$3.96B	–	+24.4%	-293.4%	+66.7%
TTM Cash From Financing	Sep 30, 26	$5.17B	+276.4%	+226.5%	+257.3%	+160.3%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
Quarterly Cash From Operations	Sep 30, 26	$3.77B	+11.5%	+24.5%	+35.8%	+7.7%
Quarterly Cash From Investing	Sep 30, 26	-$10.48B	-790.8%	-386.8%	-1464.7%	-535.2%
Quarterly Dividends Paid	Sep 30, 26	$920.84M	-5.3%	+1.5%	+26.2%	-30.1%
Quarterly Total Debt	Sep 30, 26	$31.49B	+30.1%	+31.8%	+23.8%	-8.8%
Shares Outstanding	Nov 4, 26	2.00B	–	-0.4%	-1.2%	+0.1%

Quarterly Cash From Financing Highs

GSK Quarterly Cash From Financing Highs Comparison
Period	High	Date	Current
1Y	$6.40B	Sep 30, 26	at high
3Y	$6.40B	Sep 30, 26	at high
5Y	$10.79B	Mar 31, 22	-40.7%
All	$11.63B	Jun 30, 18	-45.0%

Quarterly Cash From Financing Lows

GSK Quarterly Cash From Financing Lows Comparison
Period	Low	Date	Current
1Y	-$2.54B	Jun 30, 26	+351.6%
3Y	-$4.06B	Dec 31, 23	+257.4%
5Y	-$5.70B	Jun 30, 22	+212.2%
All	-$5.70B	Jun 30, 22	+212.2%

Quarterly Cash From Financing History

Month	Value	Change
Sep 2026	$6.40B	+351.6%
Jun 2026	-$2.54B	-1,209.8%
Mar 2026	$229.06M	-79.0%
Dec 2025	$1.09B	+163.8%
Sep 2025	-$1.71B	+38.5%
Jun 2025	-$2.78B	-323.8%
Mar 2025	$1.24B	+246.8%
Dec 2024	-$845.20M	+45.1%
Sep 2024	-$1.54B	+7.1%
Jun 2024	-$1.66B	-32.1%
Mar 2024	-$1.25B	+69.1%
Dec 2023	-$4.06B	-87.5%
Sep 2023	-$2.17B	-592.9%
Jun 2023	$439.58M	+276.5%
Mar 2023	-$249.08M	+81.0%
Dec 2022	-$1.31B	+25.2%
Sep 2022	-$1.75B	+69.3%
Jun 2022	-$5.70B	-152.8%
Mar 2022	$10.79B	+424.2%
Dec 2021	-$3.33B	-77.7%
Sep 2021	-$1.87B	+21.8%
Jun 2021	-$2.40B	-34.9%
Mar 2021	-$1.78B	+29.7%
Dec 2020	-$2.53B	+52.5%
Sep 2020	-$5.32B	-89.1%
Jun 2020	-$2.81B	-129.5%
Mar 2020	-$1.23B	+60.0%
Dec 2019	-$3.06B	-32.1%
Sep 2019	-$2.32B	-220.3%
Jun 2019	-$724.11M	-114.7%
Mar 2019	$4.92B	+223.6%
Dec 2018	-$3.98B	-62.3%
Sep 2018	-$2.45B	-121.1%
Jun 2018	$11.63B	+4,567.5%
Mar 2018	-$260.23M	+93.0%
Dec 2017	-$3.70B	-334.8%
Sep 2017	-$850.57M	+2.9%
Jun 2017	-$876.28M	+50.1%
Mar 2017	-$1.75B	-53.8%
Dec 2016	-$1.14B	+67.7%
Sep 2016	-$3.53B	-176.4%
Jun 2016	-$1.28B	+26.5%
Mar 2016	-$1.74B	-3.9%
Dec 2015	-$1.67B	+25.0%
Sep 2015	-$2.23B	+30.2%
Jun 2015	-$3.20B	-24.1%
Mar 2015	-$2.58B	-20.5%
Dec 2014	-$2.14B	-894.5%
Sep 2014	-$214.98M	+82.3%
Jun 2014	-$1.21B	+60.3%
Mar 2014	-$3.05B	-39.3%
Dec 2013	-$2.19B	-43.4%
Sep 2013	-$1.53B	+44.5%
Jun 2013	-$2.75B	-118.2%

Month	Value	Change
Mar 2013	-$1.26B	-18.7%
Dec 2012	-$1.06B	+41.8%
Sep 2012	-$1.83B	-375.8%
Jun 2012	$662.09M	+136.2%
Mar 2012	-$1.83B	-26.7%
Dec 2011	-$1.45B	+50.6%
Sep 2011	-$2.92B	-29.0%
Jun 2011	-$2.27B	-4.9%
Mar 2011	-$2.16B	-67.7%
Dec 2010	-$1.29B	-8.0%
Sep 2010	-$1.19B	+50.9%
Jun 2010	-$2.43B	+2.4%
Mar 2010	-$2.49B	-43.1%
Dec 2009	-$1.74B	-187.1%
Sep 2009	$2.00B	+171.2%
Jun 2009	-$2.81B	-383.2%
Mar 2009	-$580.56M	+68.4%
Dec 2008	-$1.84B	+46.8%
Sep 2008	-$3.45B	-172.9%
Jun 2008	$4.73B	+186.5%
Mar 2008	-$5.47B	-302.9%
Dec 2007	$2.70B	+207.6%
Sep 2007	-$2.50B	-26.3%
Jun 2007	-$1.98B	-77.7%
Mar 2007	-$1.12B	+35.0%
Dec 2006	-$1.72B	-2.0%
Sep 2006	-$1.68B	+41.1%
Jun 2006	-$2.86B	-64.7%
Mar 2006	-$1.73B	+46.0%
Dec 2005	-$3.21B	-133.0%
Sep 2005	-$1.38B	-159.7%
Jun 2005	$2.31B	+209.6%
Mar 2005	-$2.11B	-232.8%
Dec 2004	-$633.91M	+72.2%
Sep 2004	-$2.28B	-480.2%
Jun 2004	-$393.72M	+82.9%
Mar 2004	-$2.31B	-552.5%
Dec 2003	-$353.53M	+75.1%
Sep 2003	-$1.42B	+7.2%
Jun 2003	-$1.53B	-36.8%
Mar 2003	-$1.12B	-52.3%
Dec 2002	-$734.38M	+46.4%
Sep 2002	-$1.37B	+43.4%
Jun 2002	-$2.42B	-58.0%
Mar 2002	-$1.53B	+43.6%
Dec 2001	-$2.72B	-335.8%
Sep 2001	-$623.42M	+55.8%
Jun 2001	-$1.41B	-77.8%
Mar 2001	-$793.36M	+4.1%
Dec 2000	-$827.58M	-4,812.2%
Sep 2000	-$16.85M	+57.2%
Jun 2000	-$39.35M	-170.0%
Mar 2000	$56.19M	-

FAQ

What is the current quarterly cash from financing of GSK?: As of today, GSK quarterly cash from financing is $6.40B
What is GSK quarterly cash from financing most recent change?: GSK quarterly cash from financing was up +351.57% on September 30, 2026
What is 1-year change in GSK quarterly cash from financing?: GSK quarterly cash from financing is up +474.37% year-over-year
How far is GSK quarterly cash from financing from its all-time high?: GSK quarterly cash from financing is currently -44.99% below its historical high of $11.63B set on June 30, 2018
How does GSK quarterly cash from financing rank versus sector peers?: GSK quarterly cash from financing is higher than 99.90% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TTM CFF

$5.17B$8.10B+276.38%

September 30, 2026

Summary

Current Value: As of today, GSK TTM cash from financing is $5.17B, up +276.38% on September 30, 2026
Historical Performance: GSK TTM cash from financing is up +226.46% year-over-year, up +257.32% over the past 3 years
All-Time High Comparison: GSK TTM cash from financing is currently -48.87% below its historical high of $10.11B set on March 31, 2019
3-Year Low Comparison: GSK TTM cash from financing is +156.58% above its 3-year low of -$9.14B reached on June 30, 2024
Sector Comparison: GSK TTM cash from financing is higher than 99.81% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Cash From Financing	Sep 30, 26	$5.17B	+276.4%	+226.5%	+257.3%	+160.3%
Annual Cash From Financing	Dec 31, 25	-$3.96B	–	+24.4%	-293.4%	+66.7%
Quarterly Cash From Financing	Sep 30, 26	$6.40B	+351.6%	+474.4%	+395.2%	+441.5%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
TTM Cash From Operations	Sep 30, 26	$11.39B	+7.0%	+16.8%	+90.3%	+16.0%
TTM Cash From Investing	Sep 30, 26	-$16.62B	-100.4%	-174.0%	-441.5%	-717.6%
TTM Dividends Paid	Sep 30, 26	$3.61B	+0.4%	+6.9%	+28.7%	-34.7%
Quarterly Total Debt	Sep 30, 26	$31.49B	+30.1%	+31.8%	+23.8%	-8.8%
Shares Outstanding	Nov 4, 26	2.00B	–	-0.4%	-1.2%	+0.1%

TTM Cash From Financing Highs

GSK TTM Cash From Financing Highs Comparison
Period	High	Date	Current
1Y	$5.17B	Sep 30, 26	at high
3Y	$5.17B	Sep 30, 26	at high
5Y	$5.17B	Sep 30, 26	at high
All	$10.11B	Mar 31, 19	-48.9%

TTM Cash From Financing Lows

GSK TTM Cash From Financing Lows Comparison
Period	Low	Date	Current
1Y	-$4.09B	N/A	+226.5%
3Y	-$9.14B	Jun 30, 24	+156.6%
5Y	-$9.37B	Dec 31, 21	+155.2%
All	-$12.43B	Mar 31, 21	+141.6%

TTM Cash From Financing History

Month	Value	Change
Sep 2026	$5.17B	+276.4%
Jun 2026	-$2.93B	+7.4%
Mar 2026	-$3.17B	-46.9%
Dec 2025	-$2.15B	+47.3%
Sep 2025	-$4.09B	-4.3%
Jun 2025	-$3.92B	-40.0%
Mar 2025	-$2.80B	+47.1%
Dec 2024	-$5.29B	+37.8%
Sep 2024	-$8.51B	+6.9%
Jun 2024	-$9.14B	-29.8%
Mar 2024	-$7.04B	-16.6%
Dec 2023	-$6.04B	-83.7%
Sep 2023	-$3.29B	-14.4%
Jun 2023	-$2.87B	+68.1%
Mar 2023	-$9.01B	-544.9%
Dec 2022	$2.03B	>+9,900.0%
Sep 2022	$8.57M	+107.7%
Jun 2022	-$111.76M	-103.5%
Mar 2022	$3.19B	+134.1%
Dec 2021	-$9.37B	-9.4%
Sep 2021	-$8.57B	+28.7%
Jun 2021	-$12.01B	+3.4%
Mar 2021	-$12.43B	-4.6%
Dec 2020	-$11.88B	+4.3%
Sep 2020	-$12.42B	-31.8%
Jun 2020	-$9.42B	-28.5%
Mar 2020	-$7.33B	-518.4%
Dec 2019	-$1.19B	+43.6%
Sep 2019	-$2.10B	+5.9%
Jun 2019	-$2.23B	-122.1%
Mar 2019	$10.11B	+105.0%
Dec 2018	$4.93B	-5.4%
Sep 2018	$5.22B	-23.5%
Jun 2018	$6.82B	+219.9%
Mar 2018	-$5.69B	+20.8%
Dec 2017	-$7.18B	-55.3%
Sep 2017	-$4.62B	+36.7%
Jun 2017	-$7.30B	+5.2%
Mar 2017	-$7.70B	-0.2%
Dec 2016	-$7.69B	+6.5%
Sep 2016	-$8.22B	-18.8%
Jun 2016	-$6.92B	+21.7%
Mar 2016	-$8.84B	+8.7%
Dec 2015	-$9.68B	+4.6%
Sep 2015	-$10.14B	-24.8%
Jun 2015	-$8.13B	-32.3%
Mar 2015	-$6.14B	+7.2%
Dec 2014	-$6.62B	+0.8%
Sep 2014	-$6.67B	+16.4%
Jun 2014	-$7.98B	+16.2%
Mar 2014	-$9.52B	-23.2%
Dec 2013	-$7.73B	-17.1%
Sep 2013	-$6.60B	+4.3%
Jun 2013	-$6.90B	-97.9%

Month	Value	Change
Mar 2013	-$3.49B	+14.0%
Dec 2012	-$4.06B	+8.6%
Sep 2012	-$4.44B	+19.8%
Jun 2012	-$5.54B	+34.6%
Mar 2012	-$8.47B	+3.8%
Dec 2011	-$8.80B	-1.8%
Sep 2011	-$8.64B	-25.0%
Jun 2011	-$6.91B	+2.3%
Mar 2011	-$7.07B	+4.4%
Dec 2010	-$7.40B	+5.7%
Sep 2010	-$7.85B	-68.4%
Jun 2010	-$4.66B	+7.5%
Mar 2010	-$5.04B	-61.0%
Dec 2009	-$3.13B	+3.0%
Sep 2009	-$3.23B	+62.8%
Jun 2009	-$8.67B	-662.6%
Mar 2009	-$1.14B	+81.1%
Dec 2008	-$6.02B	-303.6%
Sep 2008	-$1.49B	-172.3%
Jun 2008	-$548.18M	+92.4%
Mar 2008	-$7.26B	-149.6%
Dec 2007	-$2.91B	+60.3%
Sep 2007	-$7.32B	-12.6%
Jun 2007	-$6.50B	+11.9%
Mar 2007	-$7.37B	+7.7%
Dec 2006	-$7.99B	+15.8%
Sep 2006	-$9.49B	-3.3%
Jun 2006	-$9.18B	-128.7%
Mar 2006	-$4.02B	+8.5%
Dec 2005	-$4.39B	-142.4%
Sep 2005	-$1.81B	+33.3%
Jun 2005	-$2.72B	+49.9%
Mar 2005	-$5.42B	+3.5%
Dec 2004	-$5.62B	-5.3%
Sep 2004	-$5.34B	-19.3%
Jun 2004	-$4.47B	+20.3%
Mar 2004	-$5.61B	-26.9%
Dec 2003	-$4.42B	+7.9%
Sep 2003	-$4.80B	-1.1%
Jun 2003	-$4.75B	+15.7%
Mar 2003	-$5.64B	+6.8%
Dec 2002	-$6.06B	+24.7%
Sep 2002	-$8.04B	-10.2%
Jun 2002	-$7.29B	-16.1%
Mar 2002	-$6.28B	-13.3%
Dec 2001	-$5.54B	-51.7%
Sep 2001	-$3.65B	-19.9%
Jun 2001	-$3.05B	-81.7%
Mar 2001	-$1.68B	-102.7%
Dec 2000	-$827.58M	>-9,900.0%
Sep 2000	$100.00	-100.0%
Jun 2000	$16.85M	-70.0%
Mar 2000	$56.19M	-

FAQ

What is the current TTM cash from financing of GSK?: As of today, GSK TTM cash from financing is $5.17B
What is GSK TTM cash from financing most recent change?: GSK TTM cash from financing was up +276.38% on September 30, 2026
What is 1-year change in GSK TTM cash from financing?: GSK TTM cash from financing is up +226.46% year-over-year
How far is GSK TTM cash from financing from its all-time high?: GSK TTM cash from financing is currently -48.87% below its historical high of $10.11B set on March 31, 2019
How does GSK TTM cash from financing rank versus sector peers?: GSK TTM cash from financing is higher than 99.81% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk